Mineralys Therapeutics Inc. Common Stock (MLYS) Insider Trading
- $32,705,550.00
- $2,012,335.71
- Feb. 12, 2024
- Jon Congleton
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Feb. 12, 2024 | Major Shareholder | 555,555 | $13.50 | Buy | $7,499,992.50 | |
| Nov. 22, 2023 | CEO | 4,250 | $5.97 | Buy | $25,372.50 | |
| Sept. 6, 2023 | CEO | 2,250 | $12.08 | Buy | $27,180.00 | |
| Aug. 17, 2023 | CEO | 2,250 | $12.10 | Buy | $27,225.00 | |
| Aug. 11, 2023 | insider | 157,091 | $12.81 | Sell | $2,012,335.71 | |
| Aug. 11, 2023 | CEO | 2,000 | $12.89 | Buy | $25,780.00 | |
| Feb. 14, 2023 | Director | 1,250,000 | $16.00 | Buy | $20,000,000.00 | |
| Feb. 14, 2023 | Major Shareholder | 312,500 | $16.00 | Buy | $5,000,000.00 | |
| Feb. 14, 2023 | CFO | 6,250 | $16.00 | Buy | $100,000.00 |
Insiders are both buying and selling Mineralys Therapeutics Inc. Common Stock stock.
The insider traders at Mineralys Therapeutics Inc. Common Stock are: Jon Congleton, Adam Scott Levy, David Malcom Rodman, Hbm Healthcare Investments (Ca, Ra Capital Management, L.P., and Samsara Biocapital Gp, Llc
The most active insider trader at Mineralys Therapeutics Inc. Common Stock is Jon Congleton with 4 trades.
David Malcom Rodman has sold the most Mineralys Therapeutics Inc. Common Stock stock with a total value of $4,024,671.42.
Ra Capital Management, L.P. has bought the most Mineralys Therapeutics Inc. Common Stock stock with a total value of $40,000,000.00.
The most recent insider trade for Mineralys Therapeutics Inc. Common Stock was on Feb. 12, 2024.
The single biggest insider buy for Mineralys Therapeutics Inc. Common Stock was from Ra Capital Management, L.P. with a total value of $20,000,000.00 on Feb. 14, 2023.
The single biggest insider sell for Mineralys Therapeutics Inc. Common Stock was from David Malcom Rodman with a total value of $2,012,335.71 on Aug. 11, 2023.